Which funding models to accelerate anti-parasitic and anti-infectious innovation?
Working with corporate venture funds?
Isaac joined ArchiMed in 2018. He started his professional career at Motive Partners, a private equity firm specializing in FinTech and based in London. Isaac has previously worked as a Research Associate in the Gene Editing space for HOF Capital, and as a Business Development Analyst for BioTechspert.
Isaac holds a Bachelor of Medicine degree from the University of Cambridge and a Masters in Finance and Private Equity from The London School of Economics (LSE), UK. Isaac is currently undertaking a PhD in Health Economics & Policy at the University of Lancaster, focused on public and private investment strategies in ATMPs.